Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-02

FDA Approved: ZIPRASIDONE — Supplemental Application (Dr. Reddy's Laboratories Limited)

View source ↗

Summary

FDA approves a supplemental application for ZIPRASIDONE from Dr. Reddy's Laboratories Limited, indicating the approval of a generic version under an ANDA. This …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ziprasidone (ziprasidone)

Snippet

SUPPL AP for ZIPRASIDONE (ZIPRASIDONE)